ANXA5 and irritable bowel syndrome: In order to further investigate the antitumor potential of shikonin derivatives with the strongest potential to reduce the viability of BCL1 and JVM-13 cells, flow cytometric analysis of cells stained with Annexin V and PI after exposure to IBS and MBS for 24 h was done.